Rosetta Capital Limited

About

Rosetta Capital Life Sciences Venture Investments Skip to content Menu Menu Investing. Supporting. Building. Innovative life sciences companies that improve patients’ lives. Investing. Empowering entrepreneurs to develop breakthrough innovations Supporting. Provider of resources to build world-class healthcare companies Building. Innovative companies delivering benefits to human lives About us Rosetta is a venture capital firm focused on the life sciences and medical device sectors. We are commited to transforming healthcare through our investments. founded in 0 Global investment horizon with a track record of executing transactions across North America and Europe funds raised and deployed across the life sciences and medical device sectors $ million+ in historical commitments IPO and M A exits, mostly on NASDAQ and European exchanges 0 + Read more Our Focus We invest through direct secondary transactions to provide flexible liquidity solutions to investors or corporations. Rosetta has made 50+ venture investments through direct secondary transactions over 20+ years and has vast experience of completing complex transactions in an efficient manner. Read more Transaction case studies Our People Our experienced team and advisors are specialised in the life sciences and medical device sectors, and have deep expertise in management roles, investments, transactions, and scientific acumen. Jonathan Hepple Managing Partner Read bio Ken MacLeod Partner Read bio Michael Forer Partner R

Key Contact